FI49603C - Menetelmä terapeuttisesti käytettävien oksiimien karbamoyyliestereiden valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti käytettävien oksiimien karbamoyyliestereiden valmistamiseksi.

Info

Publication number
FI49603C
FI49603C FI682886A FI288668A FI49603C FI 49603 C FI49603 C FI 49603C FI 682886 A FI682886 A FI 682886A FI 288668 A FI288668 A FI 288668A FI 49603 C FI49603 C FI 49603C
Authority
FI
Finland
Prior art keywords
oximes
preparation
therapeutically useful
carbamoyl esters
carbamoyl
Prior art date
Application number
FI682886A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI49603B (fr
Inventor
Marvin J Karten
Martin Leonard Kantor
Original Assignee
Usv Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Pharma Corp filed Critical Usv Pharma Corp
Application granted granted Critical
Publication of FI49603B publication Critical patent/FI49603B/fi
Publication of FI49603C publication Critical patent/FI49603C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furnace Housings, Linings, Walls, And Ceilings (AREA)
FI682886A 1967-11-02 1968-10-11 Menetelmä terapeuttisesti käytettävien oksiimien karbamoyyliestereiden valmistamiseksi. FI49603C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68001567A 1967-11-02 1967-11-02
US68004767A 1967-11-02 1967-11-02
US71445068A 1968-03-20 1968-03-20
US75001168A 1968-08-05 1968-08-05

Publications (2)

Publication Number Publication Date
FI49603B FI49603B (fr) 1975-04-30
FI49603C true FI49603C (fi) 1975-08-11

Family

ID=27505389

Family Applications (1)

Application Number Title Priority Date Filing Date
FI682886A FI49603C (fi) 1967-11-02 1968-10-11 Menetelmä terapeuttisesti käytettävien oksiimien karbamoyyliestereiden valmistamiseksi.

Country Status (13)

Country Link
AT (1) AT310185B (fr)
BE (1) BE722318A (fr)
BR (1) BR6803426D0 (fr)
CH (1) CH490348A (fr)
DE (1) DE1805716C3 (fr)
DK (1) DK125129B (fr)
FI (1) FI49603C (fr)
FR (1) FR8419M (fr)
GB (1) GB1214077A (fr)
IL (1) IL30810A (fr)
NL (1) NL145542B (fr)
NO (1) NO127396B (fr)
SE (1) SE356509B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2062868B1 (fr) * 1969-09-15 1973-08-10 Innothera Lab Sa
BE759128R (fr) * 1969-11-18 1971-05-18 Usv Pharma Corp Carbamoyl oximes et leur methode de
US3875232A (en) * 1971-04-08 1975-04-01 Diamond Shamrock Corp AC Ketoxime carbamates
FR2204406A1 (en) * 1972-10-26 1974-05-24 Delalande Sa 1-Phenyl-3-aminocarbonylpropan-1-one oxime carbamates - with analgesic, antiinflammatory, hypotensive and sedative activities etc.

Also Published As

Publication number Publication date
NL145542B (nl) 1975-04-15
CH490348A (fr) 1970-05-15
DE1805716B2 (de) 1973-03-22
BE722318A (fr) 1969-04-15
NL6814556A (fr) 1969-05-06
IL30810A (en) 1974-03-14
NO127396B (fr) 1973-06-18
SE356509B (fr) 1973-05-28
DE1805716C3 (de) 1973-10-18
DE1805716A1 (de) 1969-07-24
GB1214077A (en) 1970-12-02
FR8419M (fr) 1971-06-10
IL30810A0 (en) 1968-12-26
FI49603B (fr) 1975-04-30
BR6803426D0 (pt) 1973-02-22
AT310185B (de) 1973-09-25
DK125129B (da) 1973-01-02

Similar Documents

Publication Publication Date Title
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI51046C (fi) Menetelmä asetosalisyylihappotabletin valmistamiseksi.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI47364C (fi) Menetelmä terapeuttisesti arvokkaiden 3-indolyyli-alifaattinen-happoyh disteiden valmistamiseksi.
FI49958C (fi) Menetelmä terapeuttisesti aktiivisen aminoguanidiini-johdannaisen valm istamiseksi.
FI52335C (fi) Menetelmä terapeuttisesti vaikuttavien trisyklisten etyyliamiini-johda nnaisten valmistamiseksi.
FI52857C (fi) Menetelmä terapeuttisesti vaikuttavien amidoksiimien valmistamiseksi.
FI52076C (fi) Menetelmä trans-4-aminometyylisykloheksaani-1-karboksyylihapon ja 4-am inometyylibentsoehapon uusien terapeuttisesti vaikuttavien estereiden valmistamiseksi.
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI46501C (fi) Menetelmä terapeuttisesti aktiivisten, substituoitujen fenyylietikkaha ppoestereiden valmistamiseksi.
FI49603C (fi) Menetelmä terapeuttisesti käytettävien oksiimien karbamoyyliestereiden valmistamiseksi.
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
FI51472C (fi) Menetelmä hydroksihappoestereiden valmistamiseksi.
FI51812C (fi) Menetelmä alfa-aminobentsyylipenisilliinin asyylioksimetyyliestereiden valmistamiseksi.
FI50970C (fi) Menetelmä anti-fibrinolyyttisten aminometyyli-bisyklo-karboksyylihappo jen valmistamiseksi.
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
FI48833C (fi) Menetelmä terapeuttisesti käytettävien meripihkahappoimidien valmistam iseksi.
FI48724C (fi) Menetelmä N-karbamoyylioksifenyylikarbamaattien valmistamiseksi.
FI47097C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi